STAAR Surgical (STAA) dropped 5% after proxy adviser Glass Lewis recommended holders reject the revised $30.75 a share offer ...

Alcon announced that it entered into an amended merger agreement for its planned acquisition of Staar Surgical.

STAAR Surgical's major shareholder intends to vote against the acquisition, stating the price still significantly undervalues ...

Swiss eyecare giant Alcon has made a new offer for Staar Surgical worth $1.6 billion, it said on Tuesday, as it seeks to ...

Bank of America has taken a sharper turn on Alcon , issuing a double downgrade that shifts the Swiss eye-care group from buy ...

Investing.com -- Bank of America double downgraded Alcon to Underperform and cut its price objective to 60 CHF from 80 CHF, ...

Alcon (ALC) stock slips as Bank of America downgrades, citing earnings downside risk for the firm amid slower adoption of its Unity surgical platforms. Read more here.

The activist investor Broadwood, which owns 30.2% of Staar's stock, said it believes Staar is worth substantially more than the new, higher offer from Alcon. It said it would vote against the revised ...

The amended offer adds $150 million to Alcon’s original offer of $28 per share, or $1.5 billion, announced back in August.

Eye care company Alcon will offer $150 million more to buy Staar Surgical. Under the terms of the amended agreement, Alcon will purchase all outstanding shares of Staar, for $30.75 per share in cash.

Alcon increases its acquisition offer for STAAR Surgical, emphasizing a final deal amid shareholder debates and delays in the ...

Major STAAR shareholders reject Alcon's increased $30.75 bid, citing a flawed sale process, insufficient valuation, and ...